title: Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome.
abstract: Several proteins have been postulated as possible targets of immune attack in Lambert-Eaton myasthenic syndrome (LEMS). Heterogeneity of autoantibodies in sera from 20 LEMS patients was studied by comparing their reactivity to synaptotagmin, a synaptic vesicle protein, and voltage-gated calcium channels (VGCCs). Six patients' sera (1 with small cell lung carcinoma (SCLC)) contained antibodies specifically recognizing the recombinant synaptotagmin on immunoblots. Thirteen (11 with SCLC) and 16 (11 with SCLC and 1 with poorly differentiated cell carcinoma in the lung) patients' sera immunoprecipitated omega-conotoxin GVIA-labeled N-type and omega-conotoxin MVIIC-labeled Q-type VGCCs, respectively. Three of 6 synaptotagmin-positive sera had cross-reactivity with N and/or Q subtypes of VGCC; the remaining 3 showed no cross-reactivity with VGCCs. Results indicate that LEMS sera are heterogeneous in the spectrum of containing antibodies, and suggest that this heterogeneity reflects the immune response to various synaptic proteins including not only multiple VGCCs but also synaptosecretory complex proteins.
authors.affiliation: Department of Neurology, Kanazawa University School of Medicine, Ishikawa-ken, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Takamori
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
authors.forename: Y
authors.initials: Y
authors.lastname: Yasukawa
authors.forename: K
authors.initials: K
authors.lastname: Iwasa
authors.forename: Y
authors.initials: Y
authors.lastname: Nemoto
authors.forename: A
authors.initials: A
authors.lastname: Suenaga
authors.forename: S
authors.initials: S
authors.lastname: Nagataki
authors.forename: T
authors.initials: T
authors.lastname: Nakamura
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001323:Autoantibodies / Q000097:blood*; D015220:Calcium Channels / Q000276:immunology*; D002135:Calcium-Binding Proteins; D018288:Carcinoma, Small Cell / Q000276:immunology / Q000503:physiopathology; D002454:Cell Differentiation / Q000276:immunology; D005260:Female; D006801:Humans; D015151:Immunoblotting; D015640:Ion Channel Gating; D015624:Lambert-Eaton Myasthenic Syndrome / Q000276:immunology / Q000503:physiopathology*; D008175:Lung Neoplasms / Q000276:immunology / Q000503:physiopathology; D008297:Male; D008562:Membrane Glycoproteins / Q000276:immunology*; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000276:immunology*; D010257:Paraneoplastic Syndromes / Q000276:immunology / Q000503:physiopathology; D011233:Precipitin Tests; D011994:Recombinant Proteins / Q000276:immunology; D050857:Synaptotagmins
chemical_list: D001323:Autoantibodies; D015220:Calcium Channels; D002135:Calcium-Binding Proteins; D008562:Membrane Glycoproteins; D009419:Nerve Tissue Proteins; D011994:Recombinant Proteins; D050857:Synaptotagmins